News

New principal owner

2019-12-09

Glactone Pharma AB’s principal owner AQILION AB is selling its entire stake in the portfolio company Glactone Pharma... [Read more]

2019-12-09

Glactone Pharma:s huvudägare AQILION AB säljer hela sitt aktieinnehav i portföljbolaget Glactone Pharma AB till Daniel Lifveredson Invest... [Read more]

Glactone Pharma: STAT3 interacts with the androgen receptor and is a drug target in enzalutamide resistant prostate cancer

2018-11-27

In collaboration with researchers at Vancouver Prostate Centre in Canada, Glactone Pharma has discovered a novel way of... [Read more]

Glactone Pharma: STAT3 interagerar med androgenreceptorn och är en läkemedelsmåltavla i enzalutamide-resistent prostatacancer

2018-11-27

I samarbete med forskare vid Vancouver Prostate Centre i Kanada har Glactone Pharma upptäckt ett nytt sätt att... [Read more]

Glactone Pharma receives funding from Swelife and Medtech4health

2018-05-24

In strong competition and after external examination, Glactone Pharma in collaboration with researchers from Karolinska Institutet and Lund... [Read more]

Glactone Pharma erhåller finansiering från Swelife och Medtech4health

2018-05-24

I stark konkurrens och efter extern granskning har Glactone Pharma i samarbete med forskare från Karolinska Institutet och... [Read more]

Glactone Pharma receives new funding from Vinnova

2017-11-20

In strong competition and after external examination, Glactone Pharma has been awarded a SEK 886,500 grant (approx. USD... [Read more]

Glactone Pharma granted patent for STAT3 inhibitors

2017-05-12

Glactone Pharma has been granted a Swedish patent covering novel synthetic analogs of the STAT3 inhibitor GPA500 with... [Read more]

Glactone Pharma receives funding from Vinnova

2017-04-10

In strong competition and after external examination, Glactone Pharma has been awarded a Vinnova (Sweden’s Innovation Agency) grant... [Read more]

Glactone Pharma to participate at ACCR Annual Meeting 2016, April 16-20, in New Orleans, USA

2016-04-13

Glactone Pharma will participate at the American Association of Cancer Research (ACCR) Annual meeting which is one of... [Read more]